Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Investigation of obesity and incretins: evaluation of new treatments for type 2 diabetes
2010-024024-14Phase 3Active
- Sponsor
- CAIBER
- Start
- Jan 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3 trial of liraglutide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by CAIBER. Primary endpoints: Biochemical resolution of diabetes at 1 year and Biochemical resolution of diabetes at 2 years. Started Jan 2011; status: active.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2010-024024-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024024-14.